| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/27/2002 | EP1189602A1 Morphine sulphate microgranules, method for preparing same and compositions containing same |
| 03/27/2002 | EP1189598A1 A method for the improvement of transport across adaptable semi-permeable barriers |
| 03/27/2002 | EP1189597A1 Oil-core compositions for the sustained release of hydrophobic drugs |
| 03/27/2002 | EP1189594A1 Cosmetic compositions |
| 03/27/2002 | EP1189593A1 Cosmetic compositions containing pantothenic acid |
| 03/27/2002 | EP1189592A1 Cosmetic compositions containing a quaternary ammonium compound and tocopherol |
| 03/27/2002 | EP1189591A1 Cosmetic method |
| 03/27/2002 | EP1189590A1 Cosmetic compositions |
| 03/27/2002 | EP1189585A1 Cosmetic skin care compositions containing cumic alcohol |
| 03/27/2002 | EP1189584A1 Alpha amino acid composition and method for the treatment of skin |
| 03/27/2002 | EP1189583A1 Indole derivatives |
| 03/27/2002 | EP1189581A1 Topical anti-microbial compositions |
| 03/27/2002 | EP1189578A1 Cosmetic compositions |
| 03/27/2002 | EP1189575A2 Oxidatively stable, long-chain ethyl ester emollients |
| 03/27/2002 | EP1189522A1 Use of nanoscale sterols and sterol esters |
| 03/27/2002 | EP1189504A1 Pyrithione biocides enhanced by silver, copper, or zinc ions |
| 03/27/2002 | EP1124817A4 Method of preparing delta-9-tetrahydrocannabinol esters |
| 03/27/2002 | EP1064284B1 Hypnotic beta-carboline derivatives, process for their preparation and their use as medicinal products |
| 03/27/2002 | EP1036187A4 Process for the preparation of immunomodulatory polysaccharides from aloe |
| 03/27/2002 | EP1023299B1 Combined generation of phosphinic acid derivatives |
| 03/27/2002 | EP1007534A4 Bh3 interacting domain death agonist |
| 03/27/2002 | EP0946562B1 PYRROLO[3,4-d]PYRIMIDINONE DERIVATIVES AND THEIR USE AS IMMUNOSUPPRESSANTS |
| 03/27/2002 | EP0946503B1 Nitromethylthiobenzene derivatives as inhibitors of aldose reductase |
| 03/27/2002 | EP0946176B1 The use of 7-(2-oxa-5,8-diazabicyclo 4.3.0]non-8-yl)-quinolone carboxylic acid and naphthyridon carboxylic acid derivatives for manufacture of a medicament for the treatment of helicobacter pylori infections and associated gastroduodenal diseases |
| 03/27/2002 | EP0942719B1 (r)-verapamil as a medicament for the treatment of angina |
| 03/27/2002 | EP0934249B1 Conformationally restricted polyamines and their use as antineoplastic agents |
| 03/27/2002 | EP0934062B1 Antioxidant activity of 3-dehydroshikimates |
| 03/27/2002 | EP0932597B1 Use of gamma-hydroxybutyric acid amides in the treatment of drug addiction and in particular of alcoholism |
| 03/27/2002 | EP0904339B1 Sterol extraction with a polar solvent to give low sterol microbial oil |
| 03/27/2002 | EP0888293B1 N-acylaminoalkylhydrazinecarboximidamides |
| 03/27/2002 | EP0873336B1 Antagonists of gonadotropin releasing hormone |
| 03/27/2002 | EP0870018B1 Antitumour vector constructs and methods |
| 03/27/2002 | EP0865421B1 Arylethanolamine derivatives and their use as agonists of atypical beta-adrenoceptors |
| 03/27/2002 | EP0862915B1 Antibacterial composition for oral administration |
| 03/27/2002 | EP0858445B1 New [(3-alkoxy-phenoxy)-ethyl]-dialkylamine derivatives and their use as local anaesthetics |
| 03/27/2002 | EP0843661B1 (1s,2s)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanolmethanesulfonate trihydrate |
| 03/27/2002 | EP0840607B1 Novel medical use |
| 03/27/2002 | EP0837673B1 Polymeric lamellar substrate particles for drug delivery |
| 03/27/2002 | EP0832079B1 Anti-ischaemic hydroxylamine derivatives and pharmaceutical compositions |
| 03/27/2002 | EP0820287B1 Thrombin inhibitors |
| 03/27/2002 | EP0801564B1 Use of nebivolol as an anti-atherogenic |
| 03/27/2002 | EP0799056B1 Use of a nk-1 receptor antagonist and an opioid analgesic |
| 03/27/2002 | EP0792153B1 Compositions containing lazaroids and their use for preventing adhesions |
| 03/27/2002 | EP0790996B1 Pyridazinoquinoline compounds |
| 03/27/2002 | EP0787005B1 Dermatological compositions containing benzoyl peroxide and a compound reducing skin irritation |
| 03/27/2002 | EP0786998B1 Use of r-(z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo 2.2.2] oct-3-yl) acetonitrile to reduce amyloid beta a4 formation in alzheimer's disease |
| 03/27/2002 | EP0782574B1 Bicyclic carboxamides as 5-ht1a receptors ligands |
| 03/27/2002 | EP0782448B1 Non-irritation, non-sensitizing, non-ototoxic otic antibacterial compositions |
| 03/27/2002 | EP0773946B1 Imidazopyridine-azolidinones |
| 03/27/2002 | EP0766670B1 Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 03/27/2002 | EP0734255B1 Novel potassium channel agonist produced from trichoderma virens |
| 03/27/2002 | EP0705273B1 17-halogeno-4-azaandrostene derivatives and process for the preparation thereof |
| 03/27/2002 | EP0705272B1 Novel process for preparing 17 beta-substituted 4-azaandrostane derivatives |
| 03/27/2002 | EP0651746B1 Drugs that enhance synaptic responses mediated by ampa receptors |
| 03/27/2002 | EP0608341B1 Enzyme-orthokeratology |
| 03/27/2002 | CN1342193A Method for obtaining oil that rich in hydroxyoctadecadienoic fatty acids (hode) or esters thereof from mixture containing linoleic acid or esters thereof |
| 03/27/2002 | CN1342171A Process for production of multiple cross-linked hyaluronic acid derivatives |
| 03/27/2002 | CN1342170A Process for cross-linking hyaluronic acid to polymers |
| 03/27/2002 | CN1342169A Oxetanone derivatives |
| 03/27/2002 | CN1342165A Neurotrophic growth factor |
| 03/27/2002 | CN1342163A Ketolide antibiotics |
| 03/27/2002 | CN1342162A Substituted 2-acyl-3-(heteroaryl)-imidazo [1,2-a] pyrimidines, and related pharmaceutical compoistions and methods |
| 03/27/2002 | CN1342161A Tricyclic inhibitors of poly(ADP-ribose) polymerases |
| 03/27/2002 | CN1342160A Crystal modification (of 8-cyano-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-[4.3.0] nonan-8-yl)-6 Fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic |
| 03/27/2002 | CN1342158A 4-heterocyclysulfonamidyl-6-methoxy-5-(2-methoxy-phenoxy)-2-pyridyl-pyrimidine derivatives, their preparation and use as endothelin receptor antagonists |
| 03/27/2002 | CN1342157A Substituted pyrazoles ASP38 kinase inhibitors |
| 03/27/2002 | CN1342156A Inhibition and treatment of hepatitis B virus and flavivirus by helioxanthin and its analogs |
| 03/27/2002 | CN1342155A Method for high yield extraction of paclitaxel from paclitaxel-containing material |
| 03/27/2002 | CN1342153A Benzoylguanidine derivatives with advantageous properties, method for producing them and their use in production of medicaments |
| 03/27/2002 | CN1342151A 喹啉和喹喔啉化合物 Quinoline and quinoxaline compounds |
| 03/27/2002 | CN1342150A Quinoline and quinoxaline compounds as PDGF-receptor and/or LCK tyrosine kinase inhibitors |
| 03/27/2002 | CN1342149A Prostaglandin endoperoxide H synthase biosynthesis inhibitors |
| 03/27/2002 | CN1342147A NItroxyderivatives having antiinflammatory, analgesic and antithrombotic activity |
| 03/27/2002 | CN1342146A Substituted 1-oxo-and 1,3-dioxoisoindolines and their use in pharmaceutical compositions for reducing inflammatory cytokine levels |
| 03/27/2002 | CN1342145A Fused-ring compounds and use thereof as drugs |
| 03/27/2002 | CN1342143A N-substituted indolines as estrogenic agents |
| 03/27/2002 | CN1342140A 硫代酰胺衍生物 Thioamide derivatives |
| 03/27/2002 | CN1342139A Serine protease inhibitors |
| 03/27/2002 | CN1342099A Chemical method for making pyrithione particle dispersions |
| 03/27/2002 | CN1342096A Synergistic tumorcidal response induced by histamine |
| 03/27/2002 | CN1342091A Combinations of cardiovascular indications |
| 03/27/2002 | CN1342090A Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular disease |
| 03/27/2002 | CN1342089A Combinations of ileal bile acid transport inhibitors and cholestery ester transfer protein inhibitors for cardiovascular disease |
| 03/27/2002 | CN1342087A Preparations stabilized over long time |
| 03/27/2002 | CN1342083A Uses of 1-amino-3-(N,N-dimethylamino)propylidene-1,1-bisphosphonic acid |
| 03/27/2002 | CN1342082A Use of tianeptin in production of medicaments to treat neurodegenerative pathologies |
| 03/27/2002 | CN1342081A Triazineon compounds for treating diseases due to sarcosystis, neospora and toxoplasma |
| 03/27/2002 | CN1342080A Use of 5-HT5-ligands in treatment of neurodegenerative and neuropsychiatric disturbances |
| 03/27/2002 | CN1342079A Treatment and prevention of reactive oxygen metablite-mediated cellular damage |
| 03/27/2002 | CN1342078A Use of 3-isoxazolidinones and hydroxylamine acids for treatment of infections |
| 03/27/2002 | CN1342077A Inhibition of formation of vascular hyperpermeability |
| 03/27/2002 | CN1342076A Methods and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors |
| 03/27/2002 | CN1342075A Liposome preparations |
| 03/27/2002 | CN1342074A Antidepressant heterocyclic compounds |
| 03/27/2002 | CN1342073A Antioxidant compositions and methods for companion animals |
| 03/27/2002 | CN1342072A Method for preventing or delaying catheter-based revascularization |
| 03/27/2002 | CN1342071A Antithrombotic use of glycine betaine |
| 03/27/2002 | CN1342070A Binding partners for 5-HT5 receptors for treatment of migraine |
| 03/27/2002 | CN1342069A Controlled-release compositions of betahistine |
| 03/27/2002 | CN1342068A Core tablet for controlled release of gliclazide after oral administration |